FTC sues insulin middlemen, saying they pocket billions while patients face high costs
This picture shows a unit dedicated to the production of insulin pens at the factory of the U.S. pharmaceutical company Eli Lilly in Fegersheim, France, on Oct. 12, 2015. Frederick…
